Abstract
C21H24ClNO3, orthorhombic, Pbcn (no. 60), a = 17.215(11) Å, b = 15.749(11) Å, c = 14.136(9) Å, V = 3832(4) Å3, Z = 8, Rgt(F) = 0.058, wRref(F2) = 0.177, T = 296(2) K.

Data collection and handling.
Crystal: | Block, yellow |
Size: | 0.32 × 0.28 × 0.25 mm |
Wavelength: | Mo Kα radiation (λ =0.71073 Å) |
μ: | 0.220 mm−1 |
Diffractometer, scan mode: | CCD area detector, Φ and ω-scans |
2θmax, completeness: | 25.0°, >99% |
N(hkl)measured, N(hkl)unique, Rint: | 18525, 3380, 0.0541 |
Criterion for Iobs, N(hkl)gt: | Iobs > 2σ(Iobs), 2176 |
N(param)refined: | 237 |
Programs: | Bruker programs [1], OLEX2 [2], SHELX [3] |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
Atom | x | y | z | Uiso*/Ueq |
---|---|---|---|---|
N1 | 0.38417(14) | 0.07907(15) | 0.67038(16) | 0.0480(6) |
H1 | 0.382670 | 0.069075 | 0.730163 | 0.058 |
Cl1 | 0.07594(6) | 0.03553(7) | 0.64578(8) | 0.0899(4) |
O1 | 0.34465(15) | 0.26977(15) | 0.42352(19) | 0.0750(8) |
O2 | 0.39095(18) | 0.32592(16) | 0.5537(2) | 0.0915(9) |
O3 | 0.38800(14) | −0.03147(13) | 0.36612(13) | 0.0575(6) |
C1 | 0.1287(2) | 0.0655(2) | 0.5469(3) | 0.0605(9) |
C2 | 0.0902(2) | 0.0811(2) | 0.4651(3) | 0.0760(11) |
H2 | 0.036355 | 0.076576 | 0.462149 | 0.091 |
C3 | 0.1322(3) | 0.1035(3) | 0.3872(3) | 0.0866(13) |
H3 | 0.106708 | 0.113216 | 0.330203 | 0.104 |
C4 | 0.2129(2) | 0.1120(2) | 0.3916(3) | 0.0724(11) |
H4 | 0.240465 | 0.127766 | 0.337859 | 0.087 |
C5 | 0.25177(18) | 0.09724(17) | 0.4751(2) | 0.0484(7) |
C6 | 0.20789(17) | 0.07292(19) | 0.5530(2) | 0.0529(8) |
H6 | 0.232581 | 0.061488 | 0.610167 | 0.063 |
C7 | 0.33959(17) | 0.10569(18) | 0.4830(2) | 0.0446(7) |
H7 | 0.360218 | 0.118024 | 0.419830 | 0.053 |
C8 | 0.36302(17) | 0.17781(18) | 0.5485(2) | 0.0451(7) |
C9 | 0.36804(19) | 0.2649(2) | 0.5126(3) | 0.0558(8) |
C10 | 0.3490(3) | 0.3533(3) | 0.3802(4) | 0.1065(17) |
H10A | 0.348447 | 0.396490 | 0.429080 | 0.128 |
H10B | 0.397441 | 0.358476 | 0.345519 | 0.128 |
C11 | 0.2884(3) | 0.3660(3) | 0.3203(4) | 0.1195(18) |
H11A | 0.292420 | 0.421430 | 0.292463 | 0.179 |
H11B | 0.289423 | 0.323771 | 0.271296 | 0.179 |
H11C | 0.240503 | 0.361728 | 0.354732 | 0.179 |
C12 | 0.37905(17) | 0.16208(18) | 0.6394(2) | 0.0467(7) |
C13 | 0.3931(2) | 0.2265(2) | 0.7154(3) | 0.0688(10) |
H13A | 0.397010 | 0.198357 | 0.775466 | 0.103 |
H13B | 0.350662 | 0.266055 | 0.716945 | 0.103 |
H13C | 0.440521 | 0.256363 | 0.702563 | 0.103 |
C14 | 0.39150(15) | 0.01270(17) | 0.60964(18) | 0.0403(7) |
C15 | 0.37588(16) | 0.02432(17) | 0.51714(18) | 0.0391(6) |
C16 | 0.39399(16) | −0.04244(18) | 0.45158(19) | 0.0412(7) |
C17 | 0.42347(18) | −0.12548(18) | 0.4897(2) | 0.0487(7) |
H17A | 0.479701 | −0.125556 | 0.485240 | 0.058 |
H17B | 0.404362 | −0.170761 | 0.449382 | 0.058 |
C18 | 0.40105(17) | −0.14539(18) | 0.5907(2) | 0.0459(7) |
C19 | 0.42054(17) | −0.06797(18) | 0.65033(19) | 0.0452(7) |
H19A | 0.398411 | −0.075298 | 0.712900 | 0.054 |
H19B | 0.476498 | −0.064294 | 0.657312 | 0.054 |
C20 | 0.3145(2) | −0.1664(2) | 0.5974(3) | 0.0685(10) |
H20A | 0.301358 | −0.178886 | 0.661964 | 0.103 |
H20B | 0.284591 | −0.118732 | 0.575994 | 0.103 |
H20C | 0.303248 | −0.214905 | 0.558603 | 0.103 |
C21 | 0.4485(2) | −0.2213(2) | 0.6259(3) | 0.0715(10) |
H21A | 0.434279 | −0.234022 | 0.690008 | 0.107 |
H21B | 0.438095 | −0.269768 | 0.586607 | 0.107 |
H21C | 0.502821 | −0.207860 | 0.623059 | 0.107 |
Source of materials
The title compound was synthesized according to reported procedures. A mixture of 1,1-dimethyl-3,5-cyclohexanedione (10 mmol), 3-chlorobenzaldehyde (10 mmol), ammonium acetate (10 mmol) and ethyl acetoacetate (10 mmol) in ethanol (100 mL) was refluxed for 2–3 h and then cooled to room temperature. After filtering the precipitates, they were sequentially washed with ice-cooled water and ethanol and then dried under vacuum.
Experimental details
H atoms were positioned geometrically and refined using a riding model, with C—H = 0.96 Å and N—H = 0.86 Å with Uiso(H) = 1.2 times Ueq(C) and 1.2 times Ueq(N).
Comment
4-Arylpolyhydroquinolines possess diverse pharmacological and biological activities such as antitumor, analgesic and ulcerogenic, anti-inflammatory, anticoagulant, phototriggering, and fungicidal properties, and can act as anticoagulants in the production of pesticides [4]. Neurofibromatosis type I(NF-1) is a complex multi-system human disorder caused by the mutation of ageneonchromosome 17 that is responsible for production of a protein called neurofibromin which is needed for normal function in many human cell types [5]. NF-1 causes tumors along the nervous system which can grow anywhere on the body. NF-1 is one of the most common genetic disorders and is not limited to any person’s race or sex [6]. Recent research has also indicated that these heterocycles is an effective treatment to shrink NF-1 and control symptoms [7].
In the crystal structure of the title compound (Figure), the six-membered ring containing nitrogen atom is slightly folded and the adjacent ring containing the keto group adopts a flattened chair conformation. The nitrogenous heterocyclic is almost perpendicular to the chlorophenyl moiety and is almost coplanar with the mean plane of the ketone ring. The bond distances and the bond angles in the title compound are comparable with those in known compounds [8], [9], [10]. Compared with the known similar structures [8], [9], [10], the main difference is that they have different functional groups. The Cl atom in the title compound was replaced by one Br atom, one -OCH3 group and one H atom in the compounds reported in reference 5, 6 and 7, respectively.
References
Bruker Smart APEX2. Bruker AXS Inc., Madison, WI, USA (2008).Search in Google Scholar
Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.: OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 42 (2009) 339–341.10.1107/S0021889808042726Search in Google Scholar
Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Search in Google Scholar PubMed PubMed Central
Du, X.; Shi, Z.; Peng, Z.; Zhao, C.; Zhang, Y.; Wang, Z.; Li, X.; Liu, G.; Li, X.: Acetoacetate induces hepatocytes apoptosis by the ROS-mediated MAPKs pathway in ketotic cows. J. Cell Physiol. 232 (2017) 3296–3308.10.1002/jcp.25773Search in Google Scholar PubMed
Song, Y.; Li, N.; Gu, J.; Fu, S.; Peng, Z.; Zhao, C.; Zhang, Y.; Li, X.; Wang, Z.; Li, X.; Liu, G.: β-Hydroxybutyrate induces bovine hepatocyte apoptosis via an ROS-p38 signaling pathway. J. Dairy Sci. 99 (2016) 9184–9198.10.3168/jds.2016-11219Search in Google Scholar PubMed
Sun, X.; Yuan, X.; Chen, L.; Wang, T.; Wang, Z.; Sun, G.; Li, X.; Li, X.; Liu, G: Histamine induces bovine rumen epithelial cell inflammatory responseviaNF-κB pathway. Cell Physiol. Biochem. 42 (2017) 1109–1119.10.1159/000478765Search in Google Scholar PubMed
Li, J.; Meng, J.; Qu, D.; Zhang, Z.-D.; Li, F.; Yang, X.-H.; Li, J.-T.; Li, M.-K.: New biscoumarin and dihydropyran derivatives as antimicrobials. Res. Chem. Intermed. 41 (2015) 8257–8267.10.1007/s11164-014-1889-xSearch in Google Scholar
Steiger, S. A.; Monacelli, A. J.; Li, C.; Hunting, J. L. Natale, N. R. The effect of bromine scanning around the phenyl group of 4-phenylquinolone derivatives. Acta Crystallogr. C70 (2014) 790–795.Search in Google Scholar
Li, J.-T.: Crystal structure of 4-(3-methoxy-phenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline- 3-carboxylic acid ethyl ester, C22H27NO4. Z. Kristallogr. − NCS 232 (2017) 251–252.10.1515/ncrs-2016-0226Search in Google Scholar
Kurbanova, M. M.; Huseynov, E. Z.; Gurbanov, A. V.; Maharramov, A. M.; Ng, S. W. Ethyl 2,7,7-trimethyl-5-oxo-4-phenyl- 1,4,5,6,7,8-hexahydroquinoline-3-carboxylate. Acta Crystallogr. E68 (2012) o2233–o2333.10.1107/S1600536812028371Search in Google Scholar PubMed PubMed Central
©2018 Wei Gou et al., published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.